Case page

Fresenius Kabi Ipsum Srl v Asst. Controller of Patents and Designs (2026)

High Court of Delhi·Jyoti Singh J·Single Judge·Decided 31 August 2026·2026 LLBiz HC (DEL) 934

Good law Appeal disposed of: the refusal of 21 November 2024 set aside and the application remanded to the Controller for a fresh decision within six months, after hearings under Sections 14 and 25, without any opinion on the merits. No further appeal traced as of 20 October 2026.

A hearing in a pre-grant opposition under Section 25(1) does not replace the applicant's hearing under Section 14; a refusal without it was set aside and remanded.

Cite this page

Fresenius Kabi Ipsum Srl v Asst. Controller of Patents and Designs, Ali on Patents, www.aop.onl/fresenius

Judgment PDF

Summary

“This appeal is filed by the Appellant under Section 117A (2) of The Patents Act, 1970” “challenging order dated 21.11.2024 passed by Respondent No. 1/Assistant Controller of Patents and Designs refusing Patent Application No. IN 201611009993 dated 22.03.2016” (para 1). The appellant’s case was that “the present invention relates to an improved process for preparation of sugammadex” (para 3). “On a pre-grant opposition dated 21.10.2021 being filed by Respondent No. 2 on 25.10.2021, patent application was refused on grounds of lack of novelty under Section 25(1)(b), lack of inventive step under Section 25(1)(e) and non-patentability under Section 3(d)” (para 41). The appellant’s first ground was “that Respondent No. 1 failed to afford an opportunity of hearing under Section 14 albeit hearing was granted under Section 25(1).” (para 42)

The Court framed the question as “whether Respondent No. 1 was justified in denying opportunity of hearing to the Appellant under Section 14 for the reason that hearing was granted during the pre-grant opposition proceeding under Section 25(1)” (para 45). Drawing on the Division Bench in Novartis v Natco Pharma (2024), it held that “Sections 14 and 25(1) are two distinct statutory pathways and do not merge” (para 47), that “Respondent No. 1 was thus under a statutory mandate to grant opportunity of hearing to the Appellant under Section 14” and that “This serious omission of Respondent No.1, in my view, vitiates the impugned order and the matter deserves re-consideration.” (para 51) “Accordingly, for all the aforesaid reasons and without expressing any opinion on the merits of the case, the impugned order dated 21.11.2024 is set aside and the matter is remanded back to Respondent No. 1 for fresh consideration” (para 59).

What the court decided

  1. The question for decision. “The neat legal nodus that arises for consideration before this Court is whether Respondent No. 1 was justified in denying opportunity of hearing to the Appellant under Section 14 for the reason that hearing was granted during the pre-grant opposition proceeding under Section 25(1). This question need not detain this Court as it stands answered in earlier decisions of this Court and other High Courts.” (para 45)
  2. The examination process. “Section 15 is a repository of the power of the Controller to either refuse the application or require the applicant to amend the specification and/or the documents therewith. This entire process, commencing from Section 12 to Section 14, is the ’examination process’, basis which the Controller exercises the power Section 15.” (para 43)
  3. Examination and opposition as separate pathways. Of Novartis v Natco Pharma (2024), the Court held: “Therefore, the upshot of the decision of the Division Bench is that Sections 14 and 25(1) are two distinct statutory pathways and do not merge and any theory of convergence must be rejected. This simply means that a hearing granted to an applicant seeking grant of patent under Section 25(1) operates in a different field and cannot be a reason enough to take away the opportunity of hearing envisaged separately under Section 14 of 1970 Act.” (para 47)
  4. Section 14 and Rule 129. “Coming to the instant case in light of the aforementioned judgements, there is merit in the contention of the Appellant that there is violation of Section 14 of 1970 Act as also 2003 Rules. Provisions of Section 14 clearly envision grant of opportunity of hearing to an applicant where the report of the Examiner received by the Controller is adverse to the applicant” “before proceeding to dispose of the application, after notifying the gist of objections to the applicant. The argument of the Appellant is strengthened by reading of Rule 129, which provides that before exercising any discretionary power, which is likely to affect an applicant for a patent adversely, Controller shall give the applicant an opportunity of hearing” (para 50)
  5. The statutory mandate. “In this context, reliance was correctly placed by the Appellant on the decision of this Court in Ferid Allani (supra), where the Court held that Rule 129 of 2003 Rules” “casts a duty on the Controller to give a hearing to an applicant before exercising any discretionary power, which is likely to affect the applicant adversely” “Respondent No. 1 was thus under a statutory mandate to grant opportunity of hearing to the Appellant under Section 14 before taking a decision to refuse the application solely on the grounds taken by Respondent No. 2 in the pre-grant opposition.” (para 51)
  6. A substantive right. “Appellant is also right in its submission that non-grant of hearing under Section 14 has deprived the Appellant of an important right to respond to the objections raised and if necessary, carry out amendments to overcome them and that this is not merely a procedural violation, but violation of a substantive right and goes to the root of the matter.” (para 51)
  7. Sufficiency of the opposition hearing. “I am unable to accept the contention of Respondent No. 1 echoed by Respondent No. 2, that grant of hearing under Section 25(1) was sufficient and there was no requirement of granting further or separate hearing under Section 14 or worse that the outcome would have been no different. This serious omission of Respondent No.1, in my view, vitiates the impugned order and the matter deserves re-consideration.” (para 51)
  8. The Patent Manual. The Court extracted clauses of the Patent Manual “which in no uncertain terms provide for a hearing to the applicant under Section 14 before taking a decision on grant or otherwise of a patent”, including: “No patent is refused without giving an opportunity of being heard under Section 14 of the Act.” (para 51)
  9. Obiter. Isolated salt and purity. “Respondent No.1 has not considered the stand of the Appellant that use of isolated salt of 3-mercaptopropionic acid versus in situ use, is fundamentally a different chemical process” “It was rightly contended by the Appellant that anticipation must be explicit and prior art must disclose every element of claimed invention in a clear and unambiguous manner and even a single distinguishing technical feature, if absent in the prior art, suffices to establish novelty.” (para 54) “Respondent No. 1 has observed that the issue of percentage purity in prior art processes does not fall within the concern of the Patent Office, which to my mind, is fallacious and accepting this stand would shut analysis of many claimed inventions.” “Appellant rightly submits that simplicity in the invention should not be a deterrent in granting patent.” (paras 54–55)
  10. Obiter. Mosaic and hindsight. “There is also merit in the submission that without any reason forthcoming in the order, Respondent No.1 has constructed a mosaic of prior arts D1, D3, D4 and D7 to come to a conclusion that the claimed invention lacks obviousness and in doing so has adopted a hindsight approach, which has been condemned by Courts in several judgments. In fact, there is no reasoning in the order as to why a person skilled in the art would take D1 as the starting point and combine teachings of D3, D4 and D7 with D1” (para 57)
  11. Disposition. “Accordingly, for all the aforesaid reasons and without expressing any opinion on the merits of the case, the impugned order dated 21.11.2024 is set aside and the matter is remanded back to Respondent No. 1 for fresh consideration of Patent Application No. IN 201611009993 dated 22.03.2016” “Fresh decision will be taken by Respondent No. 1 within a period of six months from today in accordance with law. Respondent No. 1 shall comply with the procedures laid down in Sections 14 and 15 as also Section 25 of 1970 Act and Rule 129 of 2003 Rules.” (para 59)

What the court did not decide

“Since there is non-grant of hearing under Section 14, this Court is of the view that the matter requires reconsideration by Respondent No.1 and for this reason, Court is not delving into the rival submissions of the parties on merits of the claimed invention or the pre-grant opposition, including the merits of the impugned order, lest it prejudices either party.” (para 58)

Subsequent treatment

No later judicial treatment and no further appeal traced as of 20 October 2026.

Provisions and topics

Provisions
Topics

Cited in

Case page · Page updated 13 November 2026

www.aop.onl/fresenius